NASDAQ:AVXL

Anavex Life Sciences Stock News

etoro logo Buy AVXL
*Your capital is at risk
$2.65
-0.140 (-5.03%)
At Close: Jun 03, 2026
IGC announces its financial results for the Fiscal Year Ended March 31, 2020.
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Anavex Life Sciences (AVXL –
Association for Project Management (APM), results of a study of the contribution of project management in the UK healthcare sector
Salesforce.com has a significant presence in the healthcare segment and there are indications of continued strong momentum.
NEW YORK, July 06, 2020 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated.
Regulatory News: Median Technologies (Paris:AMLDT), The Imaging Phenomics Company® (ALMDT) announced today that it has been awarded the Euronext Europ
Core Scientific, a US-based blockchain hosting provider, announced today it has partnered with New York-based investment manager Horizon Kinetics to
SEATTLE--(BUSINESS WIRE)--#DigitalMicroscopes--According to Coherent Market Insights, the global digital microscopes market is estimated to be valued at US$ 1,124.0 million in 2020, and is expected to
PARIS, FRANCE / ACCESSWIRE / July 2, 2020 / MastOR, a medical device company developing a surgical robot for laparoscopy assistance, announced today a €3M equity round through a seed investment from
La pandemia traerá un boom de inversión en biotecnología: los principales fondos españoles dan las claves para invertir en un sector muy especializado.
Sofinnova Partners announces two first investments from its MD Start III Medtech Acceleration Fund
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE